Justice for Matthew Perry: Trial Date Set for Accused Ketamine Seller
A trial date has been set for Jasveen Sangha, who is accused of selling the dose of ketamine that led to the death of actor Matthew Perry. The trial is scheduled to start on September 23, following plea agreements reached by four other defendants in the case. Sangha's trial is the only one remaining in connection with Perry's death. The federal judge overseeing the case issued an order on Tuesday confirming the trial date.
Matthew Perry, known for his role in the popular TV show "Friends," tragically passed away after consuming ketamine, a powerful anesthetic and recreational drug. The circumstances surrounding his death have led to legal proceedings against individuals involved in the sale and distribution of the substance. Sangha's trial will play a crucial role in determining accountability and justice in this case.
The upcoming trial of Jasveen Sangha will shed light on the events leading to Matthew Perry's fatal overdose. As the sole defendant facing trial in connection with Perry's death, Sangha's case will be closely watched by the public and the entertainment industry. The trial is expected to provide insight into the illegal drug trade and its impact on individuals, families, and communities.
The trial of Jasveen Sangha is a significant development in the legal proceedings related to Matthew Perry's death. As the last remaining defendant facing charges in this case, Sangha's trial will be a pivotal moment in seeking justice for the loss of a beloved actor. The trial is set to begin on September 23, marking a crucial step in the pursuit of accountability and closure for Perry's family, friends, and fans.